Citizens Reiterates Market Perform on enGene Therapeuticsto Market Perform

Benzinga Newsdesk www.benzinga.com Neutral 83.0%

Neg 0% Neu 83% Pos 0%

Citizens analyst Silvan Turkcan reiterates enGene Therapeutics (NASDAQ:ENGN) from Market Perform to Market Perform.

Comments

No comments yet. Be the first!